Robotic intervention for improving posture and reaching in children with cerebral palsy

Postural Control Intervention With the Robotic Trunk-Support-Trainer (TruST) in Children With Cerebral Palsy: A Randomized Controlled Trial

Not applicable Interventional Teachers College, Columbia University · NCT04897347

This study is testing a robotic device to see if it can help children with cerebral palsy improve their posture and reaching skills better than regular support.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment82 (estimated)
Ages6 Years to 17 Years
SexAll
SponsorTeachers College, Columbia University Academic / other
Locations2 sites (New York, New York and 1 other locations)
Trial IDNCT04897347 on ClinicalTrials.gov

What this trial studies

This study aims to evaluate the effectiveness of a robotic device called the Trunk-Support-Trainer (TruST) in enhancing postural and reaching control in children with cerebral palsy. It involves a randomized control trial with 82 participants aged 6 to 17 years, comparing the TruST intervention to traditional static trunk support. Both groups will engage in play and functional activities designed to improve motor skills, but the TruST group will receive tailored assistance to progress their postural tasks. The study focuses on children classified as GMFCS levels III and IV, who have specific trunk control abilities.

Who should consider this trial

Good fit: Ideal candidates are children aged 6-17 years with bilateral cerebral palsy classified as GMFCS levels III or IV.

Not a fit: Patients with absent head control, severe dyskinesia, or significant spinal deformities may not benefit from this intervention.

Why it matters

Potential benefit: If successful, this intervention could significantly improve motor control and functional abilities in children with cerebral palsy.

How similar studies have performed: Other studies have shown promise in using robotic devices for motor learning in children with cerebral palsy, suggesting potential for success in this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 6-17 years
* Diagnosis of Bilateral CP: diplegia, triplegia, or quadriplegia
* Gross Motor Function Classification Systems-Expanded \& Review (GMFCS) levels III or IV
* Ability to sit 5s with trunk support between mid-ribs and pelvis (SATCo = 3-7)
* Cognitive capacity to follow basic verbal instructions (i.e., "do not put your hands on your lap" or "follow and reach the toy")

Exclusion Criteria:

* Absent head control (SATCo = 1)
* Current medical illness unrelated to CP at the time of the study
* Severe dyskinesia that prevents the child from maintaining sitting and recovering balance during reaching movements
* History of recurrent seizures (daily) or drug-resistance epilepsy
* Severe Spinal Deformities: scoliosis \>40◦ and/or kyphosis \>45◦
* Spinal osteosynthesis or orthopedic surgery of spine, upper or lower extremities in the last 6 months
* Severe spasticity of biceps/triceps in both upper extremities (Modified Ashworth Scale = 4)
* Local chemodenervation therapy in spastic muscles (e.g., botulinum toxin or phenol injections) in upper or lower extremities in the previous 3 months or planned during the study
* Other major surgeries in the previous 6 months (if medically contraindicated)

Where this trial is running

New York, New York and 1 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Cerebral PalsyPostureReachingRoboticsMotor LearningMotor Control
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.